Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cell Genesys, Inc. reported financial results for the second quarter 2009. The company reported a net loss of $3.8 million, for the second quarter of 2009, compared to a net loss of $2.8 million for the corresponding period in 2008. The increase in net loss was primarily the result of recognizing non–cash losses in 2009 related to a warrant liability as compared to recognizing non–cash gains in 2008, partially offset by gains from the repurchase and exchange of convertible senior notes in 2009.

Today in Financial Reports...keeping you current

VA Re-Ups with QuadraMed
HealthDataManagement, 12/18/09

Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address